151 related articles for article (PubMed ID: 9532616)
1. Sn-mesoporphyrin suppression of hyperbilirubinemia in EHBR/Eis rats, an animal model of Dubin-Johnson syndrome.
Drummond GS; Kappas A
Pharmacology; 1998 Mar; 56(3):158-64. PubMed ID: 9532616
[TBL] [Abstract][Full Text] [Related]
2. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin.
Martinez JC; Garcia HO; Otheguy LE; Drummond GS; Kappas A
Pediatrics; 1999 Jan; 103(1):1-5. PubMed ID: 9917431
[TBL] [Abstract][Full Text] [Related]
3. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
Kappas A; Drummond GS; Munson DP; Marshall JR
Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
[TBL] [Abstract][Full Text] [Related]
4. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin.
Valaes T; Drummond GS; Kappas A
Pediatrics; 1998 May; 101(5):E1. PubMed ID: 9565434
[TBL] [Abstract][Full Text] [Related]
5. Reduction of the C2 and C4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme catabolism.
Drummond GS; Galbraith RA; Sardana MK; Kappas A
Arch Biochem Biophys; 1987 May; 255(1):64-74. PubMed ID: 3592668
[TBL] [Abstract][Full Text] [Related]
6. Studies on the mechanism of Sn-protoporphyrin suppression of hyperbilirubinemia. Inhibition of heme oxidation and bilirubin production.
Simionatto CS; Anderson KE; Drummond GS; Kappas A
J Clin Invest; 1985 Feb; 75(2):513-21. PubMed ID: 3838318
[TBL] [Abstract][Full Text] [Related]
7. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin.
Valaes T; Petmezaki S; Henschke C; Drummond GS; Kappas A
Pediatrics; 1994 Jan; 93(1):1-11. PubMed ID: 8265301
[TBL] [Abstract][Full Text] [Related]
8. Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies.
Wagner KR; Hua Y; de Courten-Myers GM; Broderick JP; Nishimura RN; Lu SY; Dwyer BE
Cell Mol Biol (Noisy-le-grand); 2000 May; 46(3):597-608. PubMed ID: 10872746
[TBL] [Abstract][Full Text] [Related]
9. Tin-mesoporphyrin in the treatment of refractory hyperbilirubinemia due to Rh incompatibility.
Maisels MJ; Yang H
J Perinatol; 2012 Nov; 32(11):899-900. PubMed ID: 23128060
[TBL] [Abstract][Full Text] [Related]
10. Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant.
Reddy P; Najundaswamy S; Mehta R; Petrova A; Hegyi T
J Perinatol; 2003 Sep; 23(6):507-8. PubMed ID: 13679941
[TBL] [Abstract][Full Text] [Related]
11. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns.
Kappas A; Drummond GS; Henschke C; Valaes T
Pediatrics; 1995 Apr; 95(4):468-74. PubMed ID: 7700742
[TBL] [Abstract][Full Text] [Related]
12. An experimental model of postnatal jaundice in the suckling rat. Suppression of induced hyperbilirubinemia by Sn-protoporphyrin.
Drummond GS; Kappas A
J Clin Invest; 1984 Jul; 74(1):142-9. PubMed ID: 6547455
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of oral tin mesoporphyrin prophylaxis in reducing bilirubin production after an oral heme load in a transgenic mouse model.
DeSandre GH; Wong RJ; Morioka I; Contag CH; Stevenson DK
Biol Neonate; 2006; 89(3):139-46. PubMed ID: 16205054
[TBL] [Abstract][Full Text] [Related]
14. Tin-protoporphyrin suppression of hyperbilirubinemia in mutant mice with severe hemolytic anemia.
Sassa S; Drummond GS; Bernstein SE; Kappas A
Blood; 1983 May; 61(5):1011-3. PubMed ID: 6687556
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hyperbilirubinemia pharmacologic approach SnMP(tin-mesoporphyrin).
Martínez JC; García HO; Otheguy LE; Drummond GS; Kappas A
J Perinatol; 2001 Dec; 21 Suppl 1():S101-3; discussion S104-7. PubMed ID: 11803428
[No Abstract] [Full Text] [Related]
16. Characterization of porphyrin heme oxygenase inhibitors.
Vreman HJ; Cipkala DA; Stevenson DK
Can J Physiol Pharmacol; 1996 Mar; 74(3):278-85. PubMed ID: 8773407
[TBL] [Abstract][Full Text] [Related]
17. Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation.
Drummond GS; Kappas A
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6466-70. PubMed ID: 6947237
[TBL] [Abstract][Full Text] [Related]
18. Suppression of hyperbilirubinemia in the rat neonate by chromium-protoporphyrin. Interactions of metalloporphyrins with microsomal heme oxygenase of human spleen.
Drummond GS; Kappas A
J Exp Med; 1982 Dec; 156(6):1878-83. PubMed ID: 6897419
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of severe neonatal hyperbilirubinemia.
Drummond GS; Kappas A
Semin Perinatol; 2004 Oct; 28(5):365-8. PubMed ID: 15686268
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of a heme oxygenase inhibitor with a lyophilized liposomal tin mesoporphyrin formulation.
Cannon JB; Martin C; Drummond GS; Kappas A
Pharm Res; 1993 May; 10(5):715-21. PubMed ID: 8321837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
